Yüklüyor......
Statin-induced inhibition of the Rho-signaling pathway activates PPARα and induces HDL apoA-I
Statins are inhibitors of the rate-limiting enzyme in cholesterol synthesis, 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase. In addition to reducing LDL cholesterol, statin treatment increases the levels of the antiatherogenic HDL and its major apolipoprotein apoA-I. Here, we investigated...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
American Society for Clinical Investigation
2001
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC209316/ https://ncbi.nlm.nih.gov/pubmed/11390424 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|